IBIO, INC. Common Stock, Value, Issued
IBIO, INC. (IBIO) had Common Stock, Value, Issued of $56.00 thousand as of 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-28
- 2026-06-30: Common Stock, Value, Issued $56.00K.
- 2026-03-31: Common Stock, Value, Issued $35.00K.
- 2025-12-31: Common Stock, Value, Issued $30.00K.
- 2025-09-30: Common Stock, Value, Issued $20.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $56.00K 10-K · filed 2026-08-28 | |
| 2026-03-31 | $35.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $30.00K 10-Q · filed 2026-02-10 | |
| 2025-09-30 | $20.00K 10-Q/A · filed 2025-11-17 | |
| 2025-06-30 | $19.00K 10-K · filed 2026-08-28 | |
| 2025-03-31 | $10.00K 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $9.00K 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $9.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $9.00K 10-K · filed 2025-09-05 | |
| 2024-03-31 | $9.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $30.00K 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $28.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.00K 10-K/A · filed 2024-09-24 | $20.00K 10-K · filed 2023-09-27 |
| 2023-03-31 | $16.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $12.00K 10-Q/A · filed 2023-05-19 | |
| 2022-09-30 | $9.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.00K 10-K · filed 2023-09-27 | |
| 2022-03-31 | $218.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $218.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $217.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $9.00K 10-K · filed 2022-10-11 | $217.00K 10-K · filed 2021-09-28 |
| 2021-03-31 | $216.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $212.00K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $180.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $140.00K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $107.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $55.00K 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $24.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $20.00K 10-K · filed 2020-10-13 | |
| 2019-03-31 | $20.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $19.00K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $18.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $16.00K 10-K · filed 2019-08-26 | |
| 2018-03-31 | $116.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $115.00K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $93.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.00K 10-K · filed 2018-09-18 | $89.00K 10-K · filed 2017-09-15 |
| 2017-03-31 | $89.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $89.00K 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $89.00K 10-Q · filed 2016-11-18 | |
| 2016-06-30 | $89.00K 10-K · filed 2017-09-15 | |
| 2016-03-31 | $83.00K 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $77.00K 10-Q · filed 2016-02-22 | |
| 2015-09-30 | $77.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $77.00K 10-K · filed 2016-10-13 | |
| 2015-03-31 | $74.00K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $72.00K 10-Q · filed 2015-02-24 | |
| 2014-09-30 | $68.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $66.00K 10-K · filed 2015-10-13 | |
| 2014-03-31 | $66.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $64.00K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $57.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $57.00K 10-K · filed 2014-09-29 | |
| 2013-03-31 | $47.77K 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $47.77K 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $47.77K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $48.00K 10-K/A · filed 2013-10-04 | $47.77K 10-K/A · filed 2012-10-15 |
| 2012-03-31 | $47.77K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $32.38K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $32.38K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $32.38K 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |